Female repro (FGT) pathology Flashcards
Abnormal endometrial cycles: Dysfunctional Uterine Bleeding (DUB)
- Unopposed estrogen effect
- Exogenous progesterone effect
- Inadequate luteal phase
- Persistent luteal phase
Inadequate luteal phase
- Irregular ripening
- Inadequate corpus luteum – (↓ progesterone)
- Poorly developed secretory endometrium
- Breaks down irregularly (DUB)
- Bx: Poor and immature secretory glands
- Low Progesterone, FSH, LH
- Sx of infertility
Persistent luteal phase
- If C.L. continues to secrete low levels of progesterone – protracted and irregular shedding.
- Periods regular but bleeding excessive and prolonged (10 – 14 days)
- Bx. – persistent secretory even after 5 days of menstruation.
Endometriosis
- Occurrence of endometrial tissue at a site other than the lining of uterine activity.
- Adenomyosis (Endometrosis interna) – myometrium > 3mm
- diffuse, focal (adenomyoma)
- Extrauterine–ovary,tubes,parametrium,gut serosa, umbilicus
- Laparotomy or Caesarian scars
- Rarely lung, pleura, bones.
Structure
- glands, stroma
- – discolored nodules; large, blood-filled cysts; adhesions
- cyclical bleeding (less in extrauterine)
- hemosiderin, fibrosis
- chocolate cysts ovary
- fallopian tubal scars – infertility
Pathogenesis
- metaplasia of celomic epithelium
- retrograde flow through FT
- vascular dissemination
Sx
- Reproductive phase of life
- Asymptomatic
- Pain
- severe Dysmenorrhea (uterus may be retroverted), menorrhagia, infertility
- Cyclical bleeding – urinary tract, rectum, umbilicus, surgical scars
- Fibrosis – infertility (tubes), intestinal obstruction
- risk of anatomical based lesions:
- tubal pregnancy,
- urinary obstruction,
- carcinoma if ovary involvement (Pathoma)
- Regression following pregnancy, oral contraceptives

Endometritis
Cyclical shedding of endometrium (no foot hold)
Acute
- postpartum (puerperal sepsis), offensive lochia (foul smelling)
- Ascending gonococcal
- Pyometrum (obstruction of os by neoplasm, fibrosis)
- Sx: fever, abnormal uterine bleeding, and pelvic pain (Pathoma)
Chronic
- nonspecific chronic inflammation
- characterized by plasma cells
- Causes: IUD, retained products of conception, chronic PID (chlamydia), and tb
- Sx: abnl uterine bleeding, pelvic pain, and infertility

Endometrial hyperplasia
- Excess unopposed estrogen effect
- Perimenopausal metrorrhagia
- Simple cystic, complex with/without atypia
- Reversible with progesterone therapy
- Atypia, Carcinoma in situ, endometrial carcinoma
- Look for source of estrogen – (ovary, adrenals, HRT )
Simple cystic hyperplasia
- no back to back gland
Complex endometrial hyperplasia
- shortened cycle
- cribriform pattern
- back to back glands
CRITERIA FOR ATYPICAL HYPERPLASIA -> most important predictor for carcinoma
Nuclear enlargement (2-3 times of RBC)
- Pleomorphism
- Vesicular change
- Chromatin irregularity
- Loss of polarity
- Prominent nucleoli
- Cellular stratification
Note: Carcinoma cannot be excluded so implicated rx include:
- progesterone therapy
- surgical excision
Endometrial polyp
- Perimenopausal, 0.5 – 3 cm
- Extreme response to hyperplasia -> protrusion of endometrium
- Asymptomatic, or metrorrhagia
- Malignant transformation very rare
- Causes: side effect of tamoxifen (Pathoma)

Endometrial carcinoma
- gland constitute more than 50% of stroma
- glands extend into myometrium
- 55 – 65 years
- endometrial carcinoma: old
- cervical carcinoma: Young
- Unopposed estrogen effect
- Preceded by:
- hyperplasia -> endometrioid histo
- sporadic -> serous/papillary w no evident precursor lesion & assoc w p53 mutation (Pathoma)
- Obesity, diabetes, hypertension, nulliparous
- Post menopausal bleeding
- Endometrial biopsy for diagnosis
Pathogenesis
- Polypoid fungating mass in the cavity
- Asymmetric enlargement of uterus
- Back to back glands
Spread
- local, myometrium, cervix, vagina, rectum
- peritoneal
- lymphatic – iliac, paraaortic
- blood – lung, liver
Malignant mixed Mullerian tumor
(Mixed mesodermal tumor)
- admixture of carcinoma and sarcoma
- >55years
- From residual Mullerian
- mosodermal cells in endometrium
- Large, fleshy mass, hemorrhage, necrosis
- Epithelial and mesenchymal (leio, rhabdo, chondro, osteo)
- Poor prognosis
Leiomyoma

- no nuclear atypia
- no evidence of necrosis
- whirled and criss-cross appearance of smooth muscle
- estrogen-dependent
- Common (25%), benign smooth muscle tumor
- 20 – 40 years, estrogen dependant growth -> premenopausal women
- (regress with menopause)
- Multiple – subserous, intramural, submucous
- Circumscribed, whorled white nodules
- Resemble normal smooth muscle, fibrosis (fibroid)
- No malignant potential
Leiomyosarcoma
- Rare, de novo and not from leiomyoma
- Older women, post menopausal bleed
- Large, bulky single lesion, hemorrhage, necrosis
- Hypercellular with atypia
- > 10 mitosis/10 high powered fieled (h.p.f.)
- Poor prognosis
Uterine bleeding - Possibilities
- Abortion
- DUB
- Endometriosis
- Chronic endometritis
- Endometrial hyperplasia, polyp, carcinoma
- Leiomyoma
Acute vs. chronic cervicitis
Acute
- Endocervix (not erosion)
- Gonococcal, Chlamydia, Candida,
- Trichomonas, Herpes
- Post partum, Post D and C
- Purulent vaginal discharge
Chronic
- Non-specific,incidental
- Lymphocytes and plasma cells normally present in wall
- Granularity,thickening
- Retention (Nabothian) cysts -> dilated endocervical cysts filled w mucin

Squamous metaplasia
- physiological condition
- Non-specificresponse to irritation
- No malignant potential
- upward migration of ectocervix (squamous)
- endocervix: columnar
- transitional zone
- nuclear: cytoplasm ratio nl
- no loss of polarity
- no polychromasia
- no mitotic figures
Endocervical polyp
- Pre-menopausal
- Hyperplastic glands, vascularity, edema, inflammation
- No malignant potential
Condyloma accuminatum

Condyloma accuminatum aka Anogenital warts
- eptihelial hyperplasia
- koilocytosis (arrows)
- perinuclear halo
- hyperkeratosis
- STD usually caused by HPV low risk
- Papillomatous, koilocytes, HPV 6,11 (low risk -> no malignant potential)
- Inactivate tumor suppressor genes p53, RpB and activate cyclinE, leading to uncontrolled proliferation
Etiopath:
- CPE -> koilocytosis
- rarely progress to carcinoma with LR HPV
Sx: painless warts -> mostly itching and burning in vulvar region
DDx: Condyloma latum: plaque-like lesion due to syphillitic infection

CIN I to III -> still reversible!
- HPV 16, 18, 31, 33, 35, 45 (high risk) -> produces E6 & E7
- HPV 6, 11, 40, 54 (low risk) (not associated with invasive carcinoma)
- Sexual activity at a young age
- Multiple sex partners
- Parity (>7)
- Chymydal infection
- Smoking
- High viral load
- Persistent SIL/HPV
CIN I (top image)
- top layers show koilocytotic change
- basal show dysplastic changes
- LSIL (Low-grade squamous intraepithelial lesion)
- – increased N:C ratio
- – pleomorphic, hyperchromatic nuclei
CIN II
- dysplastic expand to 2/3 of surface epithelium
- HSIL
CIN III
- no orientations bw top and bottom layers; severe dysplasia
- no Cytopathic effects (no koilocytic)
- HSIL
- Pre-malignant -> usually asx
- sx only appear during malignancy

CIN – Risk Factors
- HPV 16, 18, 31, 33, 35, 45 (high risk)
- HPV 6, 11, 40, 54 (low risk)
- (not associated with invasive carcinoma)
- Sexual activity at a young age
- Multiple sex partners
- Parity (>7)
- Chlamydial infection
- Smoking
- High viral load
- Persistent SIL/HPV
Dx:
- Pap smear
- p16 staining for both nuclear and cytoplasm; surrogate maker for HPV
Pap smear

aka cervical cytology
- Schiller test first to visualize site to take Pap smear
- alone cannot differentiate bw CIN I to III -> need biopsy
- can only differentiate bw low and high grade
- cannot detect metaplasia
- can only detect abnormal squamous cells (not adenocarcinoma) -> dysplastic
- All females should get pap smear starting at 21 for screening
Mild dysplasia (CIN I)
– increased N:C ratio
– pleomorphic, hyperchromatic nuclei
Severe dysplasia, carcinoma in situ (CIN III)
- invasive carcinoma
Cervical Carcinoma

- *Gross**
- scaly, necrotic patches
- carcinoma occurs in transformation zone (seen)
Structural changes
- firm cervix (palpable barrel cervix)
- *Microscopic**
- keratin pearls
Etiopath
- Risk factor: multiple coitus, multiparity, (pathoma) smoking, immundeficiency
- Majority squamous cell / rarely adenocarcinoma
- Gradual decline due to Pap screening
- CIN, Squamous Intraepithelial lesion (cytology)
- HPV 16, 18, HSV-2? Promoter
Clinical features
- 30 – 50 years; middle-aged
- Irregular vaginal bleeding
- Postcoital bleeding
- Vaginal discharge
- Pyometra
- *Dx**
- comb biopsy: deeper biopsy
- *C&C**
- uterine infection (pyometra)
- urine stasis
- invasive cervical carcinoma
- Exophytic–necrotic fungating mass
- Ulcerative
- Infiltrative(rare)
- microinvasive carcinoma Stage IA
- Spread: confined to uterus, beyond uterus in pelvis or lower1/3of vagina, parametrium, bladder, rectum, distant mestastasis
microinvasive carcinoma Stage IA
- Greater depth & width -> invasive squamous cell carcinoma: Depth =/< 5mm from basement membrane of the epithelium and Width no more than 7mm
- No lymphatics, blood vessels invasion
- Surgical excision curative- cone biopsy or simple hysterectomy
- Stage Ia tumours can only be diagnosed in cone biopsies or hysterectomy specimens
Adenocarcinoma
- Age – mean fourth decade
- 20% history of CIN
- Asymptomatic
- Visible lesion – absent/rare
- Multifocal 15%
- Associated lesion – CIN – 50-70%
- Associated with HPV 16, 18
- Endocervical canal
- Pyometra
- Hysterectomy
Mass lesions in Vagina
- Gartner’s duct cyst
- Adenosis, clear cell carcinoma
- Carcinoma
Gartner’s duct cyst
- Remnants of mesonephric ducts
- Anterolateral wall of vagina









